In Pharmaceutical Executive’s September 2024 issue, Asymmetry Group’s Luke Forsthoefel, Yakir Siegal, and Gregory Lief examine how evolving care delivery models—from retail clinics to digital platforms—are reshaping biopharma commercialization and go-to-market efforts. Their insights highlight the growing need for agile, site-specific strategies in the dynamic healthcare landscape.
Read the full article here: https://www.pharmexec.com/view/delivery-and-disruption-navigating-changing-care-terrain